• 1. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 2. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 3. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 4. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 5. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990

Research Brief on 2,4-dimethyl-6-oxo-1,6-dihydropyridine-3-carbonitrile (CAS: 1704-19-4) in Chemical Biology and Pharmaceutical Applications

The compound 2,4-dimethyl-6-oxo-1,6-dihydropyridine-3-carbonitrile (CAS: 1704-19-4) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile scaffold and potential therapeutic applications. This heterocyclic compound, characterized by its pyridine core and nitrile functional group, has been explored for its role in drug discovery, particularly in the development of kinase inhibitors and antimicrobial agents. Recent studies have highlighted its utility as a key intermediate in the synthesis of bioactive molecules, with promising results in preclinical models.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers investigated the structural optimization of 2,4-dimethyl-6-oxo-1,6-dihydropyridine-3-carbonitrile derivatives to enhance their inhibitory activity against cyclin-dependent kinases (CDKs). The study employed molecular docking and in vitro assays to demonstrate that modifications at the 2- and 4-positions of the pyridine ring significantly improved binding affinity and selectivity for CDK2, a target implicated in cancer progression. These findings suggest that this compound class could serve as a foundation for developing next-generation CDK inhibitors with reduced off-target effects.

Another notable application of 2,4-dimethyl-6-oxo-1,6-dihydropyridine-3-carbonitrile was reported in a 2024 ACS Infectious Diseases article, where it was utilized as a precursor for synthesizing novel antimicrobial agents. The study focused on its reactivity with various electrophiles to produce derivatives with broad-spectrum activity against multidrug-resistant bacterial strains. Mechanistic studies revealed that these derivatives disrupt bacterial cell wall synthesis by targeting penicillin-binding proteins (PBPs), offering a potential strategy to combat antibiotic resistance.

From a synthetic chemistry perspective, advances in green chemistry protocols have been applied to the production of 2,4-dimethyl-6-oxo-1,6-dihydropyridine-3-carbonitrile. A 2023 Green Chemistry paper detailed a solvent-free microwave-assisted synthesis route that achieved an 85% yield while minimizing waste generation. This environmentally friendly approach aligns with the pharmaceutical industry's growing emphasis on sustainable manufacturing practices.

Ongoing research is exploring the compound's potential in neurodegenerative diseases, with preliminary data indicating neuroprotective effects in cellular models of Parkinson's disease. The nitrile moiety appears to play a crucial role in scavenging reactive oxygen species, suggesting possible applications in oxidative stress-related disorders. However, further pharmacokinetic studies are needed to assess its blood-brain barrier permeability and metabolic stability.

In conclusion, 2,4-dimethyl-6-oxo-1,6-dihydropyridine-3-carbonitrile (CAS: 1704-19-4) represents a multifaceted scaffold with diverse pharmaceutical applications. Current research underscores its value in oncology, infectious disease, and potentially neurology, while innovations in synthetic methodology enhance its accessibility for drug discovery programs. Future directions may include structure-activity relationship studies to expand its therapeutic potential and investigations into novel biological targets.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)